Keyphrases
Weakly Basic Drug
100%
Reverse Phase High Performance Liquid Chromatography Method
100%
Salmeterol xinafoate
100%
Organic Modifier
66%
Peak Shape
33%
Bonded Phases
33%
Rapid Analytical Methods
33%
C-18
33%
High Content
33%
COPD Treatment
33%
Fluticasone Propionate
33%
Asthma Treatment
33%
Drug Substance
33%
Sampling numbers
33%
Methanol
33%
Silica
33%
Formulation Development
33%
Drug Combination
33%
Reversed-phase HPLC
33%
Reversed Phase
33%
Low Limit of Detection
33%
Mobile Phase
33%
High-throughput Analysis
33%
Column Temperature
33%
Basic Drugs
33%
Engineering
Reverse Phase High Performance Liquid Chromatography
100%
Mobile Phase Composition
50%
Lower Limit
50%
Generated Sample
50%
Flow Rate
50%
Silicon Dioxide
50%
Peak Shape
50%
Phase Column
50%
Flow Velocity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
100%
Reverse Phase High Performance Liquid Chromatography
100%
Salmeterol Xinafoate
100%
Methanol
33%
Combination Drug
33%
Chronic Obstructive Lung Disease
33%
Asthma
33%
Fluticasone Propionate
33%
Silicon Dioxide
33%
Immunology and Microbiology
Reverse Phase High Performance Liquid Chromatography
100%
Salmeterol
100%
Flow Rate
33%
Asthma
33%
Mobile Phase Composition
33%
Fluticasone Propionate
33%
Chemical Engineering
Reverse Phase High Performance Liquid Chromatography
100%
Methanol
50%
Mobile Phase Composition
50%
Propionic Acid
50%